- Home
- EDIT vs ANPA Comparison
EDIT vs ANPA Comparison
Compare EDIT & ANPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- ANPA
- Stock Information
- Founded
- EDIT 2013
- ANPA 2016
- Country
- EDIT United States
- ANPA Hong Kong
- Employees
- EDIT N/A
- ANPA N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- ANPA
- Sector
- EDIT Health Care
- ANPA
- Exchange
- EDIT Nasdaq
- ANPA Nasdaq
- Market Cap
- EDIT 269.8M
- ANPA 300.0M
- IPO Year
- EDIT 2016
- ANPA 2025
- Fundamental
- Price
- EDIT $2.40
- ANPA $27.50
- Analyst Decision
- EDIT Buy
- ANPA
- Analyst Count
- EDIT 10
- ANPA 0
- Target Price
- EDIT $4.13
- ANPA N/A
- AVG Volume (30 Days)
- EDIT 2.0M
- ANPA 6.5K
- Earning Date
- EDIT 11-10-2025
- ANPA 09-30-2025
- Dividend Yield
- EDIT N/A
- ANPA N/A
- EPS Growth
- EDIT N/A
- ANPA N/A
- EPS
- EDIT N/A
- ANPA 0.06
- Revenue
- EDIT $46,383,000.00
- ANPA $5,832,684.00
- Revenue This Year
- EDIT N/A
- ANPA N/A
- Revenue Next Year
- EDIT N/A
- ANPA N/A
- P/E Ratio
- EDIT N/A
- ANPA $454.12
- Revenue Growth
- EDIT N/A
- ANPA N/A
- 52 Week Low
- EDIT $0.91
- ANPA $2.80
- 52 Week High
- EDIT $4.54
- ANPA $54.75
- Technical
- Relative Strength Index (RSI)
- EDIT 34.46
- ANPA N/A
- Support Level
- EDIT $2.30
- ANPA N/A
- Resistance Level
- EDIT $2.55
- ANPA N/A
- Average True Range (ATR)
- EDIT 0.20
- ANPA 0.00
- MACD
- EDIT -0.00
- ANPA 0.00
- Stochastic Oscillator
- EDIT 20.00
- ANPA 0.00
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About ANPA Rich Sparkle Holdings Limited Ordinary Shares
Rich Sparkle Holdings Ltd is financial printing and corporate services provider which engaged in designing and printing financial print materials in Hong Kong. It service portfolio covers a myriad of deliverables, mainly including listing documents, financial reports, fund documents, circulars and announcements. The company's core business includes (i) financial printing services such as printing, typesetting and translation, (ii) advisory services including Environmental, Social and Governance Report and (iii) other services. Key revenue is generated from Financial printing services.